This study revealed that HDAC inhibitor, trichostatin (TSA), significantly increased RhoB expression, resulting in decreased proliferation and inhibition of cell cycle progression of ovarian cancer cells whereas the methyltransferase inhibitor, 5-Azactidine, had no effects on these functional properties. This evidence concerns the gene RHOB and ovarian carcinoma.